NeuroBionics
Seattle
About NeuroBionics
NeuroBionics Corp. researches and develops medical devices for the treatment of neurological disorders such as Parkinson’s disease, epilepsy, obesity, and depression.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $6.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2004)
- Phone: +1-206-267-3700
Industries & Categories
Biotechnology, Clinical Trials, Medical Device
Canonical: https://fsome.com/organization/neurobionics-1233222 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.